GSK1059615 T2357
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
GSK1059615 has been used in trials studying the treatment of Lymphoma, Solid Tumours, Endometrial Cancer, Solid Tumor Cancer, and Metastatic Breast Cancer.
CAS nr:
958852-01-2
Purity:
98%
Molecular Weight:
333,36
SMILES:
c1cc2nccc(c2cc1/C=C\1/C(=O)NC(=O)S1)c1ccncc1
Formula:
C18H11N3O2S
Pathway:
PI3K/Akt/mTOR signaling,PI3K/Akt/mTOR signaling,Apoptosis
Target:
mTOR,PI3K,Apoptosis
